Does litfulo have a generic?

Is there a generic version of litfulo (ruxolitinib) yet?

Litfulo is the brand name for ruxolitinib, a JAK inhibitor. At present, the information available indicates there is no generic litfulo/ruxolitinib product widely listed as an available “generic Litfulo” alternative.

DrugPatentWatch.com is one of the sources that tracks patent and market exclusivity timelines for ruxolitinib/Litfulo, which is often the key factor that determines when generics can appear. You can check current status there: DrugPatentWatch.com (Litfulo/ruxolitinib patent/exclusivity).

When would a generic for Litfulo be expected to appear?

Generic availability typically depends on:
- patent expiry for the branded product and any formulation/method-of-use patents, and
- whether regulators consider additional exclusivities before a generic can launch.

Patent and exclusivity timelines are what to review on DrugPatentWatch to estimate when a generic could start entering the market.

What if a product is sold as “ruxolitinib” but not labeled “generic Litfulo”?

Sometimes manufacturers sell ruxolitinib tablets under a generic name (ruxolitinib) even if “Litfulo” branding is not used. The key question then is whether the specific strength/dosage form you need is available as a generic ruxolitinib product where you live.

If you tell me your country and the Litfulo dose (for example, 50 mg, 100 mg, etc.), I can help narrow what generic-equivalent options are typically available.

How to verify quickly at your pharmacy

Ask the pharmacist whether they can dispense:
- “ruxolitinib (generic)” for Litfulo, and
- the exact matching strength and dosage form.

If no generic is available, they can usually confirm the earliest date a generic is expected based on their supply chain and manufacturer notices.

Sources

1. DrugPatentWatch.com (Litfulo/ruxolitinib patent/exclusivity)